{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:01:42Z","timestamp":1785265302627,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012326","name":"International Science and Technology Cooperation Programme","doi-asserted-by":"publisher","award":["GJHZ202209"],"award-info":[{"award-number":["GJHZ202209"]}],"id":[{"id":"10.13039\/501100012326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009967","name":"Xinjiang Production and Construction Corps","doi-asserted-by":"publisher","award":["2022ZD049"],"award-info":[{"award-number":["2022ZD049"]}],"id":[{"id":"10.13039\/501100009967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009967","name":"Xinjiang Production and Construction Corps","doi-asserted-by":"publisher","award":["2022ZD005"],"award-info":[{"award-number":["2022ZD005"]}],"id":[{"id":"10.13039\/501100009967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009967","name":"Xinjiang Production and Construction Corps","doi-asserted-by":"publisher","award":["2024YD008"],"award-info":[{"award-number":["2024YD008"]}],"id":[{"id":"10.13039\/501100009967","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160121"],"award-info":[{"award-number":["82160121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260817"],"award-info":[{"award-number":["82260817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["MSPY202406"],"award-info":[{"award-number":["MSPY202406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004317","name":"Shihezi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117308","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T06:32:26Z","timestamp":1757140346000},"page":"117308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Isoliquiritigenin inhibits the activation of the ANXA2\/STAT3 pathway by down-regulating TAGLN2, thereby alleviating alcoholic fatty liver"],"prefix":"10.1016","volume":"242","author":[{"given":"Furong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Hasan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengwei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-1212","authenticated-orcid":false,"given":"Shenghui","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0005","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcp.2025.117308_b0010","first-page":"2018","year":"2018"},{"issue":"8","key":"10.1016\/j.bcp.2025.117308_b0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.15585\/mmwr.mm7308a1","article-title":"Deaths from Excessive Alcohol Use - United States, 2016-2021","volume":"73","author":"Esser","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"10.1016\/j.bcp.2025.117308_b0025","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.14309\/ajg.0000000000002572","article-title":"ACG clinical guideline: alcohol-associated liver disease","volume":"119","author":"Jophlin","year":"2024","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0035","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.3390\/nu15061360","article-title":"Nutritional support for alcoholic liver disease","volume":"15","author":"Tadokoro","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2025.117308_b0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejim.2023.02.012","article-title":"Treatment of acute alcohol intoxication: the role of metadoxine","volume":"110","author":"Mirijello","year":"2023","journal-title":"Eur. J. Intern. Med."},{"issue":"5","key":"10.1016\/j.bcp.2025.117308_b0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/phrs.2001.0883","article-title":"Metadoxine prevents damage produced by ethanol and acetaldehyde in hepatocyte and hepatic stellate cells in culture","volume":"44","author":"Guti\u00e9rrez-Ruiz","year":"2001","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117308_b0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2009.07.007","article-title":"Metadoxine, an ion-pair of pyridoxine and L-2-pyrrolidone-5-carboxylate, blocks adipocyte differentiation in association with inhibition of the PKA-CREB pathway","volume":"488","author":"Yang","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bcp.2025.117308_b0055","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2005.12.016","article-title":"Clinical characteristics and prognostic markers in disulfiram-induced liver injury","volume":"44","author":"Bj\u00f6rnsson","year":"2006","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0060","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.bcp.2025.117308_b0065","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"36","key":"10.1016\/j.bcp.2025.117308_b0070","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: a review","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117308_b0075","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis","volume":"47","author":"Stewart","year":"2007","journal-title":"J. Hepatol."},{"issue":"40","key":"10.1016\/j.bcp.2025.117308_b0080","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.3748\/wjg.v20.i40.14652","article-title":"Alcoholic disease: liver and beyond","volume":"20","author":"Rocco","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2025.117308_b0085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-nutr-071812-161220","article-title":"Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolism","volume":"34","author":"Pepino","year":"2014","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.bcp.2025.117308_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101428","article-title":"CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing","volume":"57","author":"Zeng","year":"2022","journal-title":"Mol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bcp.2025.117308_b0100","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1210\/endo-124-5-2336","article-title":"Tumor necrosis factor stimulates hepatic lipid synthesis and secretion","volume":"124","author":"Feingold","year":"1989","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.bcp.2025.117308_b0105","first-page":"614","article-title":"TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c)","volume":"232","author":"Endo","year":"2007","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"3","key":"10.1016\/j.bcp.2025.117308_b0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.cmet.2014.01.002","article-title":"Peroxisomes: a nexus for lipid metabolism and cellular signaling","volume":"19","author":"Lodhi","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117308_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.694720","article-title":"Dietary betaine mitigates hepatic steatosis and inflammation induced by a high-fat-diet by modulating the Sirt1\/Srebp-1\/Ppar\u0251 pathway in Juvenile black seabream (Acanthopagrus schlegelii)","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117308_b0120","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/ddm364","article-title":"Regulation of the PTEN promoter by statins and SREBP","volume":"17","author":"Teresi","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.bcp.2025.117308_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301966","article-title":"Lemon basil seed-derived peptide: Hydrolysis, purification, and its role as a pancreatic lipase inhibitor that reduces adipogenesis by downregulating SREBP-1c and PPAR-\u03b3 in 3T3-L1 adipocytes","volume":"19","author":"Kuptawach","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117308_b0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jep.2018.12.034","article-title":"Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha","volume":"232","author":"Ren","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bcp.2025.117308_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117308_b0140","first-page":"1613","article-title":"Role of AMPK-SREBP signaling in regulating fatty acid binding-4 (FABP4) expression following ethanol metabolism","volume":"11","author":"Attal","year":"2022","journal-title":"Biology (basel)."},{"key":"10.1016\/j.bcp.2025.117308_b0145","doi-asserted-by":"crossref","unstructured":"Mustafa A M, El-Shiekh R A, Esmail M M, Hassan E, Senna M M, Ebid N, Elgindy A M. Surveying the Therapeutic Potentials of Isoliquiritigenin (ISL): A Comprehensive Review. Chem Biodivers. 2025: e202500456.","DOI":"10.1002\/cbdv.202500456"},{"issue":"4","key":"10.1016\/j.bcp.2025.117308_b0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ddr.21518","article-title":"Mechanisms underlying isoliquiritigenin-induced apoptosis and cell cycle arrest via ROS-mediated MAPK\/STAT3\/NF-\u03baB pathways in human hepatocellular carcinoma cells","volume":"80","author":"Wang","year":"2019","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bcp.2025.117308_b0155","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.2147\/DDDT.S270124","article-title":"ISL Induces apoptosis and autophagy in hepatocellular carcinoma via downregulation of PI3K\/AKT\/mTOR pathway in vivo and in vitro","volume":"14","author":"Song","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bcp.2025.117308_b0160","article-title":"Isoliquiritigenin attenuates emodin-induced hepatotoxicity in vivo and in vitro through Nrf2 pathway","volume":"261","author":"Ni","year":"2022","journal-title":"Comp. Biochem. Physiol. C: Toxicol. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117308_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114173","article-title":"Isoliquiritigenin alleviates the development of alcoholic liver fibrosis by inhibiting ANXA2","volume":"159","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.bcp.2025.117308_b0170","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.3390\/ijms22179289","article-title":"(20S) Ginsenoside Rh2 inhibits STAT3\/VEGF signaling by targeting Annexin A2","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117308_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155814","article-title":"Hydroxysafflor yellow a ameliorates alcohol-induced liver injury through PI3K\/Akt and STAT3\/NF-\u03baB signaling pathways","volume":"132","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0180","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0185","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13073-022-01077-z","article-title":"Adipose methylome integrative-omic analyses reveal genetic and dietary metabolic health drivers and insulin resistance classifiers","volume":"14","author":"Christiansen","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.bcp.2025.117308_b0190","doi-asserted-by":"crossref","unstructured":"Hwang S M, Awasthi D, Jeong J, Sandoval T A, Chae C S, Ramos Y, Tan C, Falco M M, McBain I T, Mishra B, Ivashkiv L B, Zamarin D, Cantillo E, Chapman-Davis E, Holcomb K, Morales D K, Rodriguez P C, Conejo-Garcia J R, Kaczocha M, V\u00e4h\u00e4rautio A, Song M, Cubillos-Ruiz J R. Transgelin 2 guards T cell lipid metabolic programming and anti-tumor function. Preprint. Doi: 1021203\/rs3rs-3683989\/v1. 2023.","DOI":"10.21203\/rs.3.rs-3683989\/v1"},{"issue":"4","key":"10.1016\/j.bcp.2025.117308_b0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/ol.2021.12998","article-title":"TAGLN2 promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of colorectal cancer cells by activating STAT3 signaling through ANXA2","volume":"22","author":"Zhao","year":"2021","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.bcp.2025.117308_b0200","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3892\/mmr_00000302","article-title":"Hepatocellular carcinoma-associated protein markers investigated by MALDI-TOF MS","volume":"3","author":"Chen","year":"2010","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0205","doi-asserted-by":"crossref","DOI":"10.2478\/aite-2025-0014","article-title":"TAGLN2 exacerbates acute pancreatitis-induced liver injury by increasing hepatocyte pyroptosis via kupffer cells-mediated inflammatory response","volume":"73","author":"Zhao","year":"2025","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.bcp.2025.117308_b0210","unstructured":"Council N R, Earth D o, Studies L, Research I f L A, Care C f t U o t G f t, Animals U o L. Guide for the care and use of laboratory animals [M]. The National Academies Press, Washington, DC., 2011."},{"key":"10.1016\/j.bcp.2025.117308_b0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/abr.abr_142_17","article-title":"Hepatoprotective effect of metadoxine on acetaminophen-induced liver toxicity in mice","volume":"7","author":"Mazraati","year":"2018","journal-title":"Adv. Biomed. Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117308_b0220","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.bcp.2025.117308_b0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.bcp.2025.117308_b0230","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jcmgh.2022.10.002","article-title":"Ethanol and its nonoxidative metabolites promote acute liver injury by inducing ER stress, adipocyte death, and lipolysis","volume":"15","author":"Park","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117308_b0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0168-8278(98)80202-X","article-title":"Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver","volume":"28","author":"Caballer\u00eda","year":"1998","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0240","doi-asserted-by":"crossref","first-page":"793","DOI":"10.4062\/biomolther.2024.033","article-title":"Ameliorates liver inflammation and lipogenesis by regulating JAK\/STAT3 pathway","volume":"32","author":"Noh","year":"2024","journal-title":"Biomol. Ther. (seoul)."},{"issue":"30","key":"10.1016\/j.bcp.2025.117308_b0245","doi-asserted-by":"crossref","first-page":"21268","DOI":"10.18632\/oncotarget.25066","article-title":"STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cells","volume":"9","author":"Rozovski","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0250","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.7150\/ijbs.86465","article-title":"The role of STAT3\/VAV3 in glucolipid metabolism during the development of HFD-induced MAFLD","volume":"20","author":"Jiang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bcp.2025.117308_b0255","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5958429","article-title":"Proinflammatory cytokines IL-6 and TNF-\u03b1 increased telomerase activity through NF-\u03baB\/STAT1\/STAT3 activation, and withaferin a Inhibited the signaling in colorectal cancer cells","volume":"2017","author":"Chung","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1016\/j.bcp.2025.117308_b0260","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/cells9061499","article-title":"Annexin A2 in inflammation and host defense","volume":"9","author":"Dallacasagrande","year":"2020","journal-title":"Cells"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:13:56Z","timestamp":1761455636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":52,"alternative-id":["S0006295225005738"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117308","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isoliquiritigenin inhibits the activation of the ANXA2\/STAT3 pathway by down-regulating TAGLN2, thereby alleviating alcoholic fatty liver","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117308"}}